Aspiriant LLC’s Vanguard ESG US Stock ETF ESGV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-9,950
Closed -$655K – 282
2022
Q4
$655K Buy
9,950
+4,595
+86% +$307K 0.03% 158
2022
Q3
$337K Buy
+5,355
New +$376K 0.02% 197

Other funds holding ESGV

Aspiriant LLC's ESGV Position: Q1 2023 in Review

Aspiriant LLC sold out of Vanguard ESG US Stock ETF (ESGV) in Q1 2023, closing a stake of 9,950 shares — an estimated $655K sold.

Aspiriant LLC first reported a position in ESGV in Q3 2022 and held it in 2 quarters. The position peaked at $655K in Q4 2022. 416 funds tracked by Wall St. Rank hold ESGV as of Q1 2023.

  • Aspiriant LLC reported no remaining Vanguard ESG US Stock ETF position as of Q1 2023 after selling out during the quarter.
  • Aspiriant LLC sold 9,950 Vanguard ESG US Stock ETF shares in Q1 2023, an estimated $655K.
  • Aspiriant LLC first reported a position in Vanguard ESG US Stock ETF in Q3 2022 and held it in 2 quarters.
  • Aspiriant LLC's Vanguard ESG US Stock ETF position peaked at $655K in Q4 2022.
  • 416 funds tracked by Wall St. Rank held Vanguard ESG US Stock ETF as of Q1 2023.

Based on Aspiriant LLC's 13F filing for Q1 2023, filed 27 Apr 2023.